论文部分内容阅读
目的探讨布地奈德联合静脉红霉素在重症哮喘患者急诊中的应用效果。方法选取2013年10月至2015年10月收治的重症哮喘患者80例,将其随机分为两组,对照组采用红霉素治疗,实验组采用布地奈德联合静脉红霉素治疗,比较两组疗效。结果实验组总有效率为95%,显著高于对照组(85%,P<0.05);实验组咳嗽、气促、喘息及哮鸣音消失时间显著短于对照组(P<0.05)。结论重症哮喘患者采用布地奈德联合静脉红霉素治疗效果理想,值得推广应用。
Objective To investigate the effect of Budesonide combined with intravenous erythromycin in emergency treatment of patients with severe asthma. Methods Eighty patients with severe asthma admitted from October 2013 to October 2015 were selected and randomly divided into two groups. The control group was treated with erythromycin, and the experimental group was treated with budesonide combined with intravenous erythromycin. Group efficacy. Results The total effective rate in the experimental group was 95%, which was significantly higher than that in the control group (85%, P <0.05). The disappearance time of cough, shortness of breath, wheezing and wheeze in the experimental group was significantly shorter than that in the control group (P <0.05). Conclusions The treatment of severe asthma with budesonide and intravenous erythromycin is effective and worthy of promotion.